Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Urticaria
Clinical narrative: Hives; fatigue; Nausea; muscle aches; joint aches; slight headache; arm pain; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of URTICARIA (Hives), NAUSEA (Nausea), MYALGIA (muscle aches), ARTHRALGIA (joint aches) and HEADACHE (slight headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hypertension since an unknown date and Depression since an unknown date. Concomitant products included DULOXETINE for Depression, HYDROCHLOROTHIAZIDE and LISINOPRIL for Hypertension, VITAMIN D [VITAMIN D NOS] for Vitamin D, FISH OIL.    On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm pain). On 03-Feb-2021 at 1:30 PM, the patient experienced NAUSEA (Nausea), MYALGIA (muscle aches), ARTHRALGIA (joint aches) and HEADACHE (slight headache). On 06-Feb-2021, the patient experienced FATIGUE (fatigue). On 14-Feb-2021, the patient experienced URTICARIA (Hives). On 05-Feb-2021, NAUSEA (Nausea), MYALGIA (muscle aches), ARTHRALGIA (joint aches), HEADACHE (slight headache) and PAIN IN EXTREMITY (arm pain) had resolved. At the time of the report, URTICARIA (Hives) and FATIGUE (fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided.  No treatment details were reported.  Patient stated she had a glass of wine last night on 06-Feb-2021   Most recent FOLLOW-UP information incorporated above includes: On 25-Feb-2021: No specific follow-up information recorded. This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 06-Feb-2021. The most recent information was received on 25-Feb-2021 and was forwarded to Moderna on 25-Feb-2021.    This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of URTICARIA (Hives), NAUSEA (Nausea), MYALGIA (muscle aches), ARTHRALGIA (joint aches) and HEADACHE (slight headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hypertension since an unknown date and Depression since an unknown date. Concomitant products included DULOXETINE for Depression, HYDROCHLOROTHIAZIDE and LISINOPRIL for Hypertension, VITAMIN D [VITAMIN D NOS] for Vitamin D, FISH OIL.    On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm pain). On 03-Feb-2021 at 1:30 PM, the patient experienced NAUSEA (Nausea), MYALGIA (muscle aches), ARTHRALGIA (joint aches) and HEADACHE (slight headache). On 06-Feb-2021, the patient experienced FATIGUE (fatigue). On 14-Feb-2021, the patient experienced URTICARIA (Hives). On 05-Feb-2021, NAUSEA (Nausea), MYALGIA (muscle aches), ARTHRALGIA (joint aches), HEADACHE (slight headache) and PAIN IN EXTREMITY (arm pain) had resolved. At the time of the report, URTICARIA (Hives) and FATIGUE (fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided.  No treatment details were reported.  Patient stated she had a glass of wine last night on 06-Feb-2021   Most recent FOLLOW-UP information incorporated above includes: On 25-Feb-2021: No specific follow-up information recorded.